MedPath
FDA Approval

AKYNZEO

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 10, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Palonosetron(0.28 mg in 1 1)
Fosnetupitant(260 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Helsinn Healthcare SA

481466936

Manufacturing Establishments4

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Helsinn Advanced Synthesis SA

Helsinn Therapeutics (U.S.), Inc.

Helsinn Healthcare SA

481296960

Patheon Italia S.p.A.

Helsinn Therapeutics (U.S.), Inc.

Helsinn Healthcare SA

338336589

Baxter Oncology GmbH

Helsinn Therapeutics (U.S.), Inc.

Helsinn Healthcare SA

344276063

Helsinn Birex Pharmaceuticals LTD

Helsinn Therapeutics (U.S.), Inc.

Helsinn Healthcare SA

985084409

Products4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

AKYNZEO

Product Details

NDC Product Code
69639-102
Application Number
NDA210493
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
February 10, 2023
Code: 23310D4I19Class: ACTIMQuantity: 0.28 mg in 1 1
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: T672P80L2SClass: ACTIMQuantity: 260 mg in 1 1

AKYNZEO

Product Details

NDC Product Code
69639-105
Application Number
NDA210493
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
February 10, 2023
Code: T672P80L2SClass: ACTIMQuantity: 260 mg in 20 mL
Code: 23310D4I19Class: ACTIMQuantity: 0.28 mg in 20 mL
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT

AKYNZEO

Product Details

NDC Product Code
69639-106
Application Number
NDA210493
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
February 10, 2023
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: 23310D4I19Class: ACTIMQuantity: 0.28 mg in 20 mL
Code: T672P80L2SClass: ACTIMQuantity: 260 mg in 20 mL
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT

AKYNZEO

Product Details

NDC Product Code
69639-101
Application Number
NDA205718
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
February 10, 2023
WATERInactive
Code: 059QF0KO0RClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
POLYGLYCERYL-3 DIOLEATEInactive
Code: D08AL46IU2Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
GELATINInactive
Code: 2G86QN327LClass: IACT
Code: 5D06587D6RClass: ACTIBQuantity: 0.5 mg in 1 1
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
SUCROSE LAURATEInactive
Code: 05Q7CD0E49Class: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
SODIUM STEARYL FUMARATEInactive
Code: 7CV7WJK4UIClass: IACT
CAPRYLIC/CAPRIC MONO/DIGLYCERIDESInactive
Code: U72Q2I8C85Class: IACT
GLYCERINInactive
Code: PDC6A3C0OXClass: IACT
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2UClass: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRTClass: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT
Code: 7732P08TIRClass: ACTIBQuantity: 300 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath